Boulay Brian R, Birg Aleksandr
Brian R Boulay, Division of Gastroenterology and Hepatology, Department of Medicine, University of Illinois Hospital and Health Sciences System, Chicago, IL 60612, United States.
World J Gastrointest Oncol. 2016 Jun 15;8(6):498-508. doi: 10.4251/wjgo.v8.i6.498.
Malignant obstruction of the bile duct from cholangiocarcinoma, pancreatic adenocarcinoma, or other tumors is a common problem which may cause debilitating symptoms and increase the risk of subsequent surgery. The optimal treatment - including the decision whether to treat prior to resection - depends on the type of malignancy, as well as the stage of disease. Preoperative biliary drainage is generally discouraged due to the risk of infectious complications, though some situations may benefit. Patients who require neoadjuvant therapy will require decompression for the prolonged period until attempted surgical cure. For pancreatic cancer patients, self-expanding metallic stents are superior to plastic stents for achieving lasting decompression without stent occlusion. For cholangiocarcinoma patients, treatment with percutaneous methods or nasobiliary drainage may be superior to endoscopic stent placement, with less risk of infectious complications or failure. For patients of either malignancy who have advanced disease with palliative goals only, the choice of stent for endoscopic decompression depends on estimated survival, with plastic stents favored for survival of < 4 mo. New endoscopic techniques may actually extend stent patency and patient survival for these patients by achieving local control of the obstructing tumor. Both photodynamic therapy and radiofrequency ablation may play a role in extending survival of patients with malignant biliary obstruction.
胆管癌、胰腺腺癌或其他肿瘤导致的恶性胆管梗阻是一个常见问题,可能会引起使人虚弱的症状,并增加后续手术的风险。最佳治疗方案——包括是否在切除术前进行治疗的决策——取决于恶性肿瘤的类型以及疾病分期。由于存在感染并发症的风险,一般不鼓励进行术前胆道引流,不过某些情况可能会从中受益。需要新辅助治疗的患者在尝试手术治愈前的较长时间内需要减压。对于胰腺癌患者,自膨式金属支架在实现持久减压且无支架闭塞方面优于塑料支架。对于胆管癌患者,经皮方法或鼻胆管引流治疗可能优于内镜支架置入,感染并发症或失败的风险更低。对于仅以姑息治疗为目标的晚期疾病的两种恶性肿瘤患者,内镜减压支架的选择取决于估计生存期,生存期小于4个月的患者更倾向于使用塑料支架。新的内镜技术实际上可能通过实现对阻塞性肿瘤的局部控制来延长这些患者的支架通畅时间和生存期。光动力疗法和射频消融在延长恶性胆管梗阻患者的生存期方面都可能发挥作用。